Cargando…
Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
We explored how the knowledge translation and innovation processes are structured when theyresult in innovations, as in the case of liposomal doxorubicin research. In order to map the processes, a literature network analysis was made through Cytoscape and semantic analysis was performed by GOPubmed...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161884/ https://www.ncbi.nlm.nih.gov/pubmed/25182125 http://dx.doi.org/10.1186/s12967-014-0227-9 |
_version_ | 1782334613975203840 |
---|---|
author | Fajardo-Ortiz, David Duran, Luis Moreno, Laura Ochoa, Hector Castaño, Victor M |
author_facet | Fajardo-Ortiz, David Duran, Luis Moreno, Laura Ochoa, Hector Castaño, Victor M |
author_sort | Fajardo-Ortiz, David |
collection | PubMed |
description | We explored how the knowledge translation and innovation processes are structured when theyresult in innovations, as in the case of liposomal doxorubicin research. In order to map the processes, a literature network analysis was made through Cytoscape and semantic analysis was performed by GOPubmed which is based in the controlled vocabularies MeSH (Medical Subject Headings) and GO (Gene Ontology). We found clusters related to different stages of the technological development (invention, innovation and imitation) and the knowledge translation process (preclinical, translational and clinical research), and we were able to map the historic emergence of Doxil as a paradigmatic nanodrug. This research could be a powerful methodological tool for decision-making and innovation management in drug delivery research. |
format | Online Article Text |
id | pubmed-4161884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41618842014-09-13 Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin Fajardo-Ortiz, David Duran, Luis Moreno, Laura Ochoa, Hector Castaño, Victor M J Transl Med Research We explored how the knowledge translation and innovation processes are structured when theyresult in innovations, as in the case of liposomal doxorubicin research. In order to map the processes, a literature network analysis was made through Cytoscape and semantic analysis was performed by GOPubmed which is based in the controlled vocabularies MeSH (Medical Subject Headings) and GO (Gene Ontology). We found clusters related to different stages of the technological development (invention, innovation and imitation) and the knowledge translation process (preclinical, translational and clinical research), and we were able to map the historic emergence of Doxil as a paradigmatic nanodrug. This research could be a powerful methodological tool for decision-making and innovation management in drug delivery research. BioMed Central 2014-09-03 /pmc/articles/PMC4161884/ /pubmed/25182125 http://dx.doi.org/10.1186/s12967-014-0227-9 Text en © Fajardo-Ortiz et al.; licensee BioMed Central Ltd. 2014 |
spellingShingle | Research Fajardo-Ortiz, David Duran, Luis Moreno, Laura Ochoa, Hector Castaño, Victor M Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin |
title | Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin |
title_full | Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin |
title_fullStr | Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin |
title_full_unstemmed | Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin |
title_short | Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin |
title_sort | mapping knowledge translation and innovation processes in cancer drug development: the case of liposomal doxorubicin |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161884/ https://www.ncbi.nlm.nih.gov/pubmed/25182125 http://dx.doi.org/10.1186/s12967-014-0227-9 |
work_keys_str_mv | AT fajardoortizdavid mappingknowledgetranslationandinnovationprocessesincancerdrugdevelopmentthecaseofliposomaldoxorubicin AT duranluis mappingknowledgetranslationandinnovationprocessesincancerdrugdevelopmentthecaseofliposomaldoxorubicin AT morenolaura mappingknowledgetranslationandinnovationprocessesincancerdrugdevelopmentthecaseofliposomaldoxorubicin AT ochoahector mappingknowledgetranslationandinnovationprocessesincancerdrugdevelopmentthecaseofliposomaldoxorubicin AT castanovictorm mappingknowledgetranslationandinnovationprocessesincancerdrugdevelopmentthecaseofliposomaldoxorubicin |